InvestLog
RPRX logo

RPRX

Royalty Pharma plcNASDAQHealthcare
$48.57+0.16%ClosedMarket Cap: $20.81B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-01-27Citigroup—Buy—
2025-12-11TD Cowen—Buy—
2025-10-10Morgan Stanley—Overweight—
2025-07-22Citigroup—Buy—
2025-07-10Morgan Stanley—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$5.25$3.48B4
Sun Dec 31$6.08$3.97B1
Mon Dec 31$7.04$4.59B1
Tue Dec 31$7.71$4.99B1